FDA approves first flu vaccine that can be self-administered at …
WEB1 day ago · Link Copied! The FDA approved FluMist as the first flu vaccine that can be self-administered at home. Sarah Silbiger/Getty Images. The US Food and Drug Administration on Friday approved the first ...
Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine …
WEBAug 16, 2024 · In a Phase 3 trial, Pfizer and BioNTech’s combination vaccine candidate against influenza and COVID-19 met one of its two primary immunogenicity objectives.
No needles required: The FDA approves an at-home flu vaccine
WEB1 day ago · No needles required: The FDA approves an at-home flu vaccine. A fifth-grader receives the FluMist influenza virus vaccine in Anaheim, Calif., in 2015. The Food and Drug Administration has approved the first flu vaccine that people can administer to themselves at home. The agency on Friday gave the green light for …
HHS provides $176 million to develop pandemic influenza mRNA-based vaccine
WEBJul 2, 2024 · This award will enable the rapid development of an mRNA vaccine targeted to various influenza virus subtypes, also known as strains, of pandemic potential. The award also includes the option for large-scale production and pandemic response.
No needles required: The FDA approves an at-home flu vaccine
WEB1 day ago · A fifth-grader receives the FluMist influenza virus vaccine in Anaheim, Calif., in 2015. Jeff Gritchen/Digital First Media/Orange County Register via Getty Images hide caption
Pfizer Initiates Phase 3 Study of mRNA-Based Influenza Vaccine
WEBSep 14, 2022 · First Phase 3 efficacy study to be conducted using an mRNA-based influenza vaccine; study will enroll 25,000 U.S. adults 18 years and older. Influenza causes 140,000 to 710,000 hospitalizations and 12,000 to 52,000 deaths in the U.S. every year1.
Study shows promise for a universal influenza vaccine: Scientists ...
WEBJul 19, 2024 · New research led by Oregon Health & Science University reveals a promising approach to developing a universal influenza vaccine—a so-called "one and done" vaccine that confers lifetime...
FDA approves first nasal spray flu vaccine for use at home
WEB1 day ago · By Sabrina Malhi. September 20, 2024 at 7:45 p.m. EDT. The Food and Drug Administration on Friday approved the first at-home flu vaccine, a nasal spray that consumers with a prescription will be ...
Next-generation influenza vaccines based on mRNA technology
WEB3 days ago · Thus, in The Lancet Infectious Diseases, Dense Hsu and colleagues 8 report the interim results of a safety and immunogenicity study of a panel of next-generation mRNA influenza vaccines that targeted an additional one or two influenza H3N2 strains in adults aged 50–75 years. All vaccines included the A/Darwin/6/2021 (H3N2) strain (subclade 3C.2a1b.2a.2a), one next-generation vaccine ...
Pfizer and BioNTech Announce Positive Topline Data for mRNA …
WEBOct 26, 2023 · NEW YORK & MAINZ, GERMANY-- (BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced positive topline results from a Phase 1/2 study (NCT05596734) evaluating the safety, tolerability and immunogenicity of mRNA-based combination vaccine candidates for influenza and COVID-19 among healthy adults 18 to 64 years of age.
- Some results have been removed
Skip to content